tetano
Editor, Senior Moderator
ACS Chem Neurosci
. 2020 Sep 30.
doi: 10.1021/acschemneuro.0c00596. Online ahead of print.
Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor
Rafal Butowt[SUP] 1 [/SUP], Katarzyna Bilinska[SUP] 1 [/SUP], Christopher S Von Bartheld[SUP] 2 [/SUP]
Affiliations
Abstract
After several months of rapid pandemic expansion, it is now apparent that the SARS-CoV-2 coronavirus interferes with smell and taste sensation in a substantial proportion of COVID-19 patients. Recent epidemiological data documented intriguing differences in prevalence of chemosensory dysfunctions between different world regions. Viral genetic factors as well as host genetic factors appear to be relevant; however, it is not yet known which mutations or polymorphisms actually contribute to such phenotypic differences between populations. Here, we discuss recent genetic and epidemiological data on the D614G spike protein variant and assess whether current evidence is consistent with the notion that this single nucleotide polymorphism augments chemosensory impairments in COVID-19 patients. We hypothesize that this spike variant is an important viral genetic factor that facilitates infection of chemosensory epithelia, possibly acting together with yet to be identified host factors, and thereby increases smell and taste impairment. We suggest that the prevalence of chemosensory deficits may reflect the pandemic potential for transmissibility and spread which differs between populations.
Keywords: ACE2; COVID-19; Chemosensory dysfunction; D614G mutation; D614G variant; olfactory dysfunction.
. 2020 Sep 30.
doi: 10.1021/acschemneuro.0c00596. Online ahead of print.
Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor
Rafal Butowt[SUP] 1 [/SUP], Katarzyna Bilinska[SUP] 1 [/SUP], Christopher S Von Bartheld[SUP] 2 [/SUP]
Affiliations
- PMID: 32997488
- DOI: 10.1021/acschemneuro.0c00596
Abstract
After several months of rapid pandemic expansion, it is now apparent that the SARS-CoV-2 coronavirus interferes with smell and taste sensation in a substantial proportion of COVID-19 patients. Recent epidemiological data documented intriguing differences in prevalence of chemosensory dysfunctions between different world regions. Viral genetic factors as well as host genetic factors appear to be relevant; however, it is not yet known which mutations or polymorphisms actually contribute to such phenotypic differences between populations. Here, we discuss recent genetic and epidemiological data on the D614G spike protein variant and assess whether current evidence is consistent with the notion that this single nucleotide polymorphism augments chemosensory impairments in COVID-19 patients. We hypothesize that this spike variant is an important viral genetic factor that facilitates infection of chemosensory epithelia, possibly acting together with yet to be identified host factors, and thereby increases smell and taste impairment. We suggest that the prevalence of chemosensory deficits may reflect the pandemic potential for transmissibility and spread which differs between populations.
Keywords: ACE2; COVID-19; Chemosensory dysfunction; D614G mutation; D614G variant; olfactory dysfunction.